Who owns EUPRAXIA PHARMACEUTICALS INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of EPRX from SEC Form 13F filings across 66 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 66 institutions disclosed 24.5M shares of EUPRAXIA PHARMACEUTICALS INC. worth $161.5M — about 37% of shares outstanding; the largest disclosed holder is Beutel, Goodman & Co Ltd.. Source: SEC Form 13F filings, parsed by EvidInvest.
66
13F holders
$161.5M
value, 2026 filers
37%
of shares outstanding (24.5M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of EPRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Beutel, Goodman & Co Ltd. | 3.6M | $23.8M | 0.2% | 5.5% | -1.1% |
| 2 | Affinity Asset Advisors, LLC | 1.6M | $10.9M | 0.5% | 2.5% | +3.8% |
| 3 | Balyasny Asset Management L.P. | 1.4M | $8.9M | 0.0% | 2% | 0.0% |
| 4 | Vivo Capital, LLC | 1.4M | $8.9M | 0.8% | 2% | 0.0% |
| 5 | SCOTIA CAPITAL INC. | 1.3M | $8.8M | 0.0% | 2% | +0.1% |
| 6 | PFM Health Sciences, LP | 1.2M | $8.0M | 0.7% | 1.8% | +123.8% |
| 7 | GREAT POINT PARTNERS LLC | 1.2M | $7.9M | 1.5% | 1.8% | 0.0% |
| 8 | Jupiter Topco LLCNEW | 1.0M | $6.9M | 0.0% | 1.6% | new |
| 9 | Rubric Capital Management LP | 867,424 | $5.7M | 0.1% | 1.3% | +25.5% |
| 10 | Ikarian Capital, LLC | 809,741 | $5.4M | 0.6% | 1.2% | -33.3% |
| 11 | Woodline Partners LP | 746,864 | $4.9M | 0.0% | 1.1% | +69.5% |
| 12 | Point72 Asset Management, L.P. | 730,284 | $4.8M | 0.0% | 1.1% | -24.5% |
| 13 | AMERIPRISE FINANCIAL INC | 711,024 | $4.7M | 0.0% | 1.1% | +35.6% |
| 14 | Redmile Group, LLC | 611,400 | $4.0M | 0.3% | 0.9% | -12.7% |
| 15 | Seven Fleet Capital Management LP | 610,785 | $4.0M | 0.7% | 0.9% | +40.9% |
| 16 | UBS Group AG | 519,211 | $3.4M | 0.0% | 0.8% | -31.9% |
| 17 | CITADEL ADVISORS LLC | 502,011 | $3.3M | 0.0% | 0.8% | +118.1% |
| 18 | MILLENNIUM MANAGEMENT LLCNEW | 441,586 | $2.9M | 0.0% | 0.7% | new |
| 19 | Alyeska Investment Group, L.P. | 375,000 | $2.5M | 0.0% | 0.6% | 0.0% |
| 20 | PICTON MAHONEY ASSET MANAGEMENTNEW | 360,878 | $2.4M | 0.0% | 0.5% | new |
| 21 | Velan Capital Investment Management LP | 352,000 | $2.3M | 1.4% | 0.5% | 0.0% |
| 22 | JANE STREET GROUP, LLC | 329,053 | $2.2M | 0.0% | 0.5% | +834.5% |
| 23 | Aisling Capital Management LP | 325,000 | $2.1M | 0.5% | 0.5% | 0.0% |
| 24 | ROYAL BANK OF CANADA | 311,435 | $2.1M | 0.0% | 0.5% | +19.2% |
| 25 | DV EQUITIES, LLCNEW | 276,000 | $1.8M | 0.3% | 0.4% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.